BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7438124)

  • 1. Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results.
    Mattson K; Holsti LR; Salmo M; Saastamoinen M; Ahlstedt S; Holsti P
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():65-70. PubMed ID: 7438124
    [No Abstract]   [Full Text] [Related]  

  • 2. Vindesine chemotherapy in lung cancer.
    Natale RB; Gralla RJ; Wittes RE; Golbey RB; Young CW
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():59-63. PubMed ID: 7438123
    [No Abstract]   [Full Text] [Related]  

  • 3. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
    Havemann K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
    [No Abstract]   [Full Text] [Related]  

  • 7. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
    Drings P; Kleckow M; Manke HG; Stiefel E
    Onkologie; 1984 Aug; 7(4):202-4. PubMed ID: 6384861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI; Bychkov MB
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
    Karrer K; Pridun N; Zwintz E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 15. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
    Karrer K; Pridun N; Denck H
    Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
    Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer].
    Schalhorn A
    Fortschr Med; 1985 May; 103(17):453-6. PubMed ID: 4039699
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.
    Evans BD; Smith IE; Shorthouse AJ; Millar JL
    Br J Cancer; 1982 Mar; 45(3):466-8. PubMed ID: 6280742
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 20. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.